Collectively, these investigations underscore the importance of gut–brain signaling in regulating appetite, reward, and learning, and highlight how targeted therapies, such as GLP-1 receptor agonists and mineralocorticoid receptor blockers, can beneficially modulate brain function in obesity. This evidence concerns the gene GLP1R and obesity disorder.